Please assess the completion status of the following clinical trial:

Trial Title: Impact of Rational Control of Fluid Balance in the Intensive Care Unit

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age of 18 or more~* Patients receiving endo-tracheal intubation and mechanical ventilation during their stay in the ICU~* Weight increase of at least 3 % during the stay. Baseline weight is regarded as the weight at the 24th hour after ICU admission~* FiO2 \< 60 %, PEEP \< 10cmH20~* No administration of catecholamines other than dobutamine at a dose of 10 microg.Kg-1.min-1~Exclusion Criteria:~* Pregnancy~* Patient with a moribund state at ICU arrival~* Acute brain injury (traumatic brain injury, subarachnoid hemorrhage, intra-cerebral bleeding, stroke, meningo-encephalitis, coma from medication origin)~* Chronic kidney disease defined as creatinin clearance \< 30mL.min-1 and/or with chronic dialysis~* Mandatory administration of diuretics (cardiogenic pulmonary oedema, LVEF \< 30 %)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Test Furosemide (Type: EXPERIMENTAL): We will test our furosemide algorithm in one arm
- Classical Strategy (Type: NO_INTERVENTION): It's a classical strategy without diuretics

Based on this trial design, predict the completion outcome and termination type (if applicable).